Catalysts for ViiV Healthcare Company
93 tracked
Oct 24, 2019
approval
TRIUMEQ (ABACAVIR SULFATE) — FDA approval
ViiV Healthcare Company
→
May 3, 2019
approval
TRIUMEQ (ABACAVIR SULFATE) — FDA approval
ViiV Healthcare Company
→
Apr 8, 2019
approval
DOVATO (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Sep 6, 2018
approval
JULUCA (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Sep 6, 2018
approval
JULUCA (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Sep 6, 2018
approval
TIVICAY (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Sep 6, 2018
approval
TIVICAY (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Sep 6, 2018
approval
TRIUMEQ (ABACAVIR SULFATE) — FDA approval
ViiV Healthcare Company
→
Sep 6, 2018
approval
TRIUMEQ (ABACAVIR SULFATE) — FDA approval
ViiV Healthcare Company
→
May 11, 2018
approval
TRIUMEQ (ABACAVIR SULFATE) — FDA approval
ViiV Healthcare Company
→
Jan 17, 2018
approval
JULUCA (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Nov 21, 2017
approval
JULUCA (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Nov 21, 2017
approval
TIVICAY (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Nov 21, 2017
approval
TRIUMEQ (ABACAVIR SULFATE) — FDA approval
ViiV Healthcare Company
→
Mar 27, 2017
approval
TIVICAY (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Mar 27, 2017
approval
TRIUMEQ (ABACAVIR SULFATE) — FDA approval
ViiV Healthcare Company
→
Dec 20, 2016
approval
TIVICAY (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Nov 8, 2016
approval
TIVICAY (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Jun 9, 2016
approval
TIVICAY (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Apr 22, 2016
approval
TIVICAY (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Apr 21, 2016
approval
TRIUMEQ (ABACAVIR SULFATE) — FDA approval
ViiV Healthcare Company
→
Apr 1, 2016
approval
TRIUMEQ (ABACAVIR SULFATE) — FDA approval
ViiV Healthcare Company
→
Nov 5, 2015
approval
TIVICAY (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Sep 28, 2015
approval
TRIUMEQ (ABACAVIR SULFATE) — FDA approval
ViiV Healthcare Company
→
Aug 5, 2015
approval
TIVICAY (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Aug 5, 2015
approval
TRIUMEQ (ABACAVIR SULFATE) — FDA approval
ViiV Healthcare Company
→
Jul 30, 2015
approval
TIVICAY (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Jun 15, 2015
approval
TRIUMEQ (ABACAVIR SULFATE) — FDA approval
ViiV Healthcare Company
→
Dec 19, 2014
approval
TIVICAY (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→
Aug 29, 2014
approval
TIVICAY (DOLUTEGRAVIR SODIUM) — FDA approval
ViiV Healthcare Company
→